These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
63 related articles for article (PubMed ID: 9538647)
1. [Plasma serine protease inhibitors in dialyzed patients with chronic renal insufficiency]. Kotschy M; Kassian J; Lampka M; Rajewski W Pol Merkur Lekarski; 1997 Feb; 2(8):93-5. PubMed ID: 9538647 [TBL] [Abstract][Full Text] [Related]
2. [Tissue plasminogen activator antigen (t-PA Ag) and tissue plasminogen activator inhibitor (PAI-1) in the course of hemodialysis in patients with chronic renal failure]. Piatkowska M; Kotschy M; Nartowicz E; Rajewski W Pol Merkur Lekarski; 1997 Jan; 2(9):205-7. PubMed ID: 10907030 [TBL] [Abstract][Full Text] [Related]
3. [Serine protease inhibitors in plasma of patients with ulcerative colitis]. Swiatkowski M; Pulkowski G; Kłopocka M; Budzyński J; Wiśniewsk E; Kotschy M Przegl Lek; 2001; 58(2):67-70. PubMed ID: 11475845 [TBL] [Abstract][Full Text] [Related]
4. Plasminogen activators (t-PA and u-PA) and plasminogen activators inhibitors (PAI-1 and PAI-2) in some myeloproliferative syndromes. Rość D; Kremplewska-Nalezyta E; Gadomska G; Zastawna E; Michalski A; Drewniak W Med Sci Monit; 2000; 6(4):684-91. PubMed ID: 11208392 [TBL] [Abstract][Full Text] [Related]
5. Plasma PAI-1 levels in obese children--effect of weight loss and influence of PAI-1 promoter 4G/5G genotype. Estellés A; Dalmau J; Falcó C; Berbel O; Castelló R; España F; Aznar J Thromb Haemost; 2001 Aug; 86(2):647-52. PubMed ID: 11522017 [TBL] [Abstract][Full Text] [Related]
6. Unfractionated heparin but not enoxaparin causes delayed plasma PAI-1 depletion in hemodialysis patients: a prospective study. Naumnik B; Pawlak K; Mys'liwiec M Clin Appl Thromb Hemost; 2009 Feb; 15(1):84-91. PubMed ID: 17895513 [TBL] [Abstract][Full Text] [Related]
7. Periodontitis is characterized by elevated PAI-1 activity. Bizzarro S; van der Velden U; ten Heggeler JM; Leivadaros E; Hoek FJ; Gerdes VE; Bakker SJ; Gans RO; Ten Cate H; Loos BG J Clin Periodontol; 2007 Jul; 34(7):574-80. PubMed ID: 17535288 [TBL] [Abstract][Full Text] [Related]
8. The fibrinolytic system in chronic renal failure. Lottermoser K; Petras S; Pöge U; Fimmers R; Hertfelder HJ; Schiermeyer B; Vetter H; Düsing R Eur J Med Res; 2001 Sep; 6(9):372-6. PubMed ID: 11591527 [TBL] [Abstract][Full Text] [Related]
9. Plasminogen activator inhibitor type 1 (PAI-1) in plasma and adipose tissue in HIV-associated lipodystrophy syndrome. Implications of adipokines. He G; Andersen O; Haugaard SB; Lihn AS; Pedersen SB; Madsbad S; Richelsen B Eur J Clin Invest; 2005 Sep; 35(9):583-90. PubMed ID: 16128865 [TBL] [Abstract][Full Text] [Related]
10. [Plasma serine protease inhibitors in patients with liver cirrhosis]. Piatkowska M; Kotschy M; Rość D; Wiśniewska E; Opoka J Acta Haematol Pol; 1994; 25(2):145-9. PubMed ID: 8067185 [TBL] [Abstract][Full Text] [Related]
11. High plasma fibrinogen level is associated with poor clinical outcome in DIC patients. Wada H; Mori Y; Okabayashi K; Gabazza EC; Kushiya F; Watanabe M; Nishikawa M; Shiku H; Nobori T Am J Hematol; 2003 Jan; 72(1):1-7. PubMed ID: 12508260 [TBL] [Abstract][Full Text] [Related]
12. Contribution of plasma proteinase inhibitors to the regulation of activated protein C in plasma. Marlar RA; Kressin DC; Madden RM Thromb Haemost; 1993 Jan; 69(1):16-20. PubMed ID: 8383358 [TBL] [Abstract][Full Text] [Related]
13. Laboratory evidence of hyperfibrinolysis in association with low plasminogen activator inhibitor type 1 activity. Agren A; Wiman B; Schulman S Blood Coagul Fibrinolysis; 2007 Oct; 18(7):657-60. PubMed ID: 17890953 [TBL] [Abstract][Full Text] [Related]
14. [Plasma Lp (a) levels and correlation of Lp (a) with fibrinolysis activation in chronic renal failure]. Zhu J; Xiong X; Zhao S; Wang Z; Lou L; Hang Q Hunan Yi Ke Da Xue Xue Bao; 1999; 24(4):366-8. PubMed ID: 12080650 [TBL] [Abstract][Full Text] [Related]
15. [Status of the kallikrein-kinin system, proteinase inhibitors and nonspecific resistance factors in patients with chronic kidney failure on hemodialysis as well as in kidney transplant recipients]. Shcherbakova EG; Varakina NI; Iarovaia GA; Belorusov OS; Dotsenko VL; Vorob'eva LS Vopr Med Khim; 1991; 37(5):40-3. PubMed ID: 1722060 [TBL] [Abstract][Full Text] [Related]
16. Enhancement of fibrinolysis in poorly controlled, hospitalized type 2 diabetic patients by short-term metabolic control: association with a decrease in plasminogen activator inhibitor 1. Aso Y; Okumura KI; Yoshida N; Tayama K; Takemura Y; Inukai T Exp Clin Endocrinol Diabetes; 2004 Apr; 112(4):175-80. PubMed ID: 15127320 [TBL] [Abstract][Full Text] [Related]
17. [Study of fibrinolysis inhibitors in 117 acute leukemia patients]. Wang W; Ji CY; Ye JJ; Zhu YY; Guo DM; Ji M Zhonghua Xue Ye Xue Za Zhi; 2008 Mar; 29(3):183-6. PubMed ID: 18788619 [TBL] [Abstract][Full Text] [Related]
18. Associations between apolipoprotein E gene polymorphism and plasminogen activator inhibitor-1 and atherogenic lipid profile in dialysis patients. Arikan H; Koc M; Sari H; Tuglular S; Ozener C; Akoglu E Ren Fail; 2007; 29(6):713-9. PubMed ID: 17763167 [TBL] [Abstract][Full Text] [Related]
19. Inactivation of plasminogen activator inhibitor type 1 by activated factor XII plays a role in the enhancement of fibrinolysis by contact factors in-vitro. Tanaka A; Suzuki Y; Sugihara K; Kanayama N; Urano T Life Sci; 2009 Jul; 85(5-6):220-5. PubMed ID: 19500599 [TBL] [Abstract][Full Text] [Related]
20. Discovery of PAI-1 in plasma. Wiman B Thromb Res; 2000 Oct; 100(1):7-8. PubMed ID: 11203376 [No Abstract] [Full Text] [Related] [Next] [New Search]